宁桂军,高源,吴丹,李军宏,李艺星,邵祝军,尹遵栋

• 1:中国疾病预防控制中心免疫规划中心
• 2:中国疾病预防控制中心传染病预防控制所

摘要(Abstract)：

目的分析中国(未包括中国香港特别行政区、澳门特别行政区和台湾)2011-2017年百日咳的流行病学特征。方法通过中国疾病预防控制信息系统收集2011-2017年发病的实验室和临床诊断的百日咳病例,进行描述性流行病学分析。结果 2011-2017年中国共报告百日咳32 452例,年平均发病率为0.34/10万;山东、新疆、广东、陕西和重庆的百日咳报告病例数占60.39%;5-9月病例数占54.96%;男女病例数之比为1.14∶1,发病率分别为0.36/10万和0.33/10万;<1岁儿童病例数占64.33%,发病率为19.59/10万;在<1岁儿童病例中,≤2月龄占28.05%,3-5月龄占41.95%。结论中国2011-2017年百日咳发病呈上升趋势;夏秋季、男性、小年龄儿童高发,且地区分布不均衡。建议加强百日咳监测,探索预防低龄儿童发病的免疫策略。

关键词(KeyWords)： 百日咳;流行病学

Abstract:

Keywords:

基金项目(Foundation): 中国CDC公共卫生应急反应机制的运行(131031001000150001)

作者(Author): 宁桂军,高源,吴丹,李军宏,李艺星,邵祝军,尹遵栋

参考文献(References)：

• [1]WHO.Pertussis vaccines:WHO position paper-September 2015[J].WER,2015,90(35):433-458.
• [2]CHERRY JD.Epidemic pertussis in 2012-the resurgence of a vaccine-preventable disease[J].N Engl J Med,2012,367(9):785-787.
• [3]KILGORE PE,SALIM AM,ZERVOS MJ,et al.Pertussis:microbiology,disease,treatment,and prevention[J].Clin Microbiol Rev,2016,29(3):449-486.
• [4]张兴录,杨志伟,周军,等.我国近年百日咳流行病学特点分析[J].中国计划免疫,2000,6(2):31-33.ZHANG Xinglu,YANG Zhiwei,ZHOU Jun,et al.An analysis on current epidemiological characteristics of pertussis in China[J].Chinese Journal of Vaccines and Immunization,2000,6(2):31-33.
• [5]汪海波,罗会明,温宁,等.我国2006-2010年百日咳流行病学分析[J].中国疫苗和免疫,2012,18(3):207-210.WANG Haibo,LUO Huiming,WEN Ning,et al.Epidemiological analysis on pertussis in China during 2006-2010[J].Chinese Journal of Vaccines and Immunization,2012,18(3):207-210.
• [6]崔健,曹雷,郑景山,等.中国2015年国家免疫规划疫苗报告接种率分析[J].中国疫苗和免疫,2017,23(6):601-607.CUI Jian,CAO Lei,ZHENG Jingshan,et al.Reported coverage of vaccines in the National Immunization Program of China,2015[J].Chinese Journal of Vaccines and Immunization,2017,23(6):601-607.
• [7]SKOFF TH,BAUMBACH J,CIESLAK PR.Tracking pertussis and evaluating control measures through enhanced pertussis surveillance,emerging infections program,United States[J].Emerging Infectious Diseases,2015,21(9):1568-1573.
• [8]TAN T,DALBY T,FORSYTH K,et al.Pertussis across the globe:recent epidemiologic trends from 2000 to 2013[J].Pediatr Infect Dis J,2015,34(9):e222-232.
• [9]CHERRY JD,BEER T,CHARTRAND SA,et al.Comparison of values of antibody to Bordetella pertussis antigens in young German and American men[J].Clin Infect Dis,1995,20(5):1271-1274.
• [10]VERSTEEGH FG,SCHELLEKENS JF,NAGELKERKE AF,et al.Laboratory-confirmed reinfections with Bordetella pertussis[J].Acta Paediatr,2002,91(1):95-97.
• [11]CARLSSON RM,TROLLFORS B.Control of pertussis-lessons learnt from a 10-year surveillance programme in Sweden[J].Vaccine,2009,27(42):5709-5718.
• [12]KLEIN NP,BARTLETT J,ROWHANI-RAHBAR A,et al.Waning protection after fifth dose of acellular pertussis vaccine in children[J].N Engl J Med,2012,367(11):1012-1019.
• [13]中华医学会儿科学分会感染学组,中华儿科杂志编辑委员会.中国儿童百日咳诊断及治疗建议[J].中华儿科杂志,2017,55(8):568-572.Subspecialty Group of Infectious Diseases,Society of Pediatrics,Chinese Medical Association,Editorial Board of Chinese Journal of Pediatrics.Recommendation for diagnosis and treatment of Chinese children with pertussis[J].Chin J Pediatr,2017,55(8):568-572.
• [14]HEYMANN DL.Control of communicable diseases manual[M].19th ed.Washington,DC:American Public Health Association,2008:456-457.
• [15]National Center for Immunization and Respiratory Diseases.Pertussis-annual epidemiological report 2015[R/OL].(2017-10-01)[2018-01-15].https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2015-pertussis.pdf.
• [16]HAMBORSKY J,KROGER A,WOLFE C.Epidemiology and prevention of vaccine-preventable diseases[M].13th ed.Washington DC:Public Health Foundation,2015:261-278.
• [17]PLOTKIN SA,ORENSTEIN WA,OFFIT PA.Vaccines[M].7th ed.Philadelphia,PA:Elsevier,2018:711-761.
• [18]LEURIDAN E,HENS N,PEETERS N,et al.Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants[J].Pediatr Infect Dis J,2011,30(7):608-610.
• [19]VILAJELIU A,GONCE A,LOPEZ M,et al.Combined tetanusdiphtheria and pertussis vaccine during pregnancy:transfer of maternal pertussis antibodies to the newborn[J].Vaccine,2015,33(8):1056-1062.
• [20]HEALY CM,MUNOZ FM,RENCH MA,et al.Prevalence of pertussis antibodies in maternal delivery,cord,and infant serum[J].J Infect Dis,2004,190(2):335-340.
• [21]ZHANG Q,ZHENG H,LIU M,et al.The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China:a cross sectional study[J].BMC Infect Dis,2012,12(1):138.
• [22]黄海涛,刘勇,高志刚,等.天津市2010-2012年社区人群百日咳血清流行病学调查[J].中华流行病学杂志,2014,35(12):1354-1357.HUANG Haitao,LIU Yong,GAO Zhigang,et al.A sero-epidemiological study on pertussis among the community-based populations in Tianjin during 2010-2012[J].Chin J Epidemiol,2014,35(12):1354-1357.
• [23]LI X,CHEN M,ZHANG T,et al.Seroepidemiology of diphtheria and pertussis in Beijing,China:a cross-sectional study[J].Hum Vaccin Immunother,2015,11(10):2434-2439.
• [24]中华预防医学会疫苗可预防疾病儿童百日咳临床调查研究协作组.持续性咳嗽儿童百日咳临床多中心调查研究[J].中华儿科杂志,2010,48(10):748-752.Study Group of Pediatric Clinical Investigation of Pertussis,Program for Vaccine Preventable Diseases,Chinese Association of Preventive Medicine.Multicenter clinical investigation of pertussis in children and adolescents with persistent cough[J].Chin J Pediatr,2010,48(10):748-752.